Acurx Pharmaceuticals
ACXP
ACXP
12 hedge funds and large institutions have $1.86M invested in Acurx Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
65% less capital invested
Capital invested by funds: $5.27M → $1.86M (-$3.41M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$310K | |
| 2 | +$13.8K | |
| 3 | +$1.8K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$554 |
Top Sellers
| 1 | -$2.08M | |
| 2 | -$1.06M | |
| 3 | -$24.3K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$40 |